Insomnia

Insomnia – Epidemiology – Mature Markets

DRG Epidemiology's coverage of insomnia comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (United States, France, Germany, Italy,…

Insomnia – Epidemiology – Europe

DRG Epidemiology's coverage of insomnia comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (United States, France, Germany, Italy,…

Insomnia – Epidemiology – Emerging Markets

DRG Epidemiology’s coverage of insomnia comprises epidemiological estimates of key patient populations in the emerging pharmaceutical markets (Brazil, China, India, Mexico, Russia, South Korea,…

Insomnia | DecisionBase | US/EU5 | 2014

In the Highly Genericized Insomnia Market, What Opportunities Remain for New Therapies?

We expect the prevalence of insomnia in the seven major pharmaceutical markets under study (United States,…